ConforMIS Inc. has announced its completion of an investigation about excess moisture and ethylene glycol residue on several of the company???s total knee replacement offerings, in which an independent testing laboratory found no significant health risk to patients from ethylene glycol residue on the affected instrumentation … Read the Rest
ConforMIS Announces Results of Multiple Studies of its Customized Knee Replacements Presented at the 2015 Pan Pacific International Congress for Joint Reconstruction
Bedford, Mass. ?????August 3, 2015???????ConforMIS, Inc. (NASDAQ: CFMS) announced today results from six clinical studies presented at the 2015 Pan Pacific International Congress for … Read the Rest
JFK Memorial Hospital Announces Availability of CONFORMIS Personalized Partial Knee Resurfacing System for Patients
JFK Memorial Hospital Indio, CA announced today the availability of minimally traumatic, patient-specific knee resurfacing implants, for patients suffering from osteoarthritis of the knee, a condition that affects more than 27 million adults in the U.S. … Read the Rest